Post‑discharge Management of Severe Depressive Episodes
Timely Follow‑up After Hospital Discharge
- An outpatient contact (in‑person or telephone) should be made within 1 week of discharge; early contact improves outcomes. 1
- The first 8–12 weeks post‑discharge carry the highest risk of relapse, requiring especially close monitoring during this period. 2
- A minimum of 2–3 months of intensive follow‑up is recommended to detect early signs of relapse. 2
Continuation of Antidepressant Pharmacotherapy
- For a first depressive episode, antidepressants should be continued for 6–12 months after full remission. 1
- In patients with recurrent episodes, maintenance therapy should be maintained for at least 2 years after the last episode. 3
- The therapeutic dose that achieved remission should be maintained; dose reductions are associated with a higher relapse risk. 1
Structured Monitoring Schedule
- Follow‑up visits are scheduled every 2–4 weeks initially, then monthly for 6–12 months. 1
- At each visit, residual depressive symptoms should be measured with standardized tools (e.g., PHQ‑9, BDI‑II). 4
- Suicide risk must be actively assessed at every consultation. 2
- Medication side‑effects should be systematically recorded using specific side‑effect scales. 2
- Treatment adherence is a major issue; approximately 30 % of patients are non‑compliant, contributing to treatment failure. 5
- New or persistent psychosocial stressors should be identified and addressed. 2
Psychotherapeutic Continuation
- Cognitive‑behavioral therapy (CBT) should be continued or initiated if it was not provided during inpatient care. 4
- Routine psycho‑education for patients and families is recommended to improve understanding and engagement. 3
Management of Inadequate Early Response
- If no sufficient improvement is observed after 6–8 weeks, clinicians should reassess the diagnosis, explore adherence problems, comorbid conditions, and any ongoing interpersonal conflicts or abuse. 2
- Referral to a psychiatric specialist is advised when response remains inadequate. 6
Addressing Common Comorbidities
- Anxiety disorders co‑occur in 50–60 % of depressed patients and should be treated concurrently. 5
- Substance misuse (particularly alcohol and sedatives) is strongly linked to suicidality and must be actively screened for. 7
- For treatment‑resistant depression, electroconvulsive therapy (ECT) can reduce the risk of suicide in the first year after discharge by ≈50 %. 7
Social and Lifestyle Interventions
- Promote social skills training and independent living for patients with severe courses. 3
- Provide support for re‑integration into vocational activities. 3
- Involve family members through structured family interventions. 3
Relapse Prevention Strategies
- Encourage a regular daily routine with adequate daylight exposure and physical activity to stabilize circadian rhythms. 8
- Actively prevent and treat sleep disturbances, which are associated with residual symptoms, relapse, and suicidal thoughts. 8
- Discuss early warning signs of relapse with patients and their families to enable prompt action. 3